M. Lanzino

Patient-derived organoids in functional precision oncology: from experimental models to clinical decision-making

Despite major advances in high-throughput genomics, proteomics, and multimodal imaging, a substantial gap persists between molecular tumor characterization and clinically actionable therapeutic decision-making, partly due to the limitations of conventional preclinical models in capturing tumor heterogeneity and predict...